CTNM
NASDAQ · Pharmaceuticals
Contineum Therapeutics Inc-A
$11.94
-0.22 (-1.81%)
Open$12.30
Previous Close$12.16
Day High$12.67
Day Low$11.57
52W High$16.33
52W Low$3.57
Volume—
Avg Volume249.5K
Market Cap446.39M
P/E Ratio—
EPS$-1.95
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+225.1% upside
Current
$11.94
$11.94
Target
$38.82
$38.82
$27.95
$38.82 avg
$46.43
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 273.32M | 248.64M | 220.16M |
| Net Income | 33.71M | 25.85M | 22.01M |
| Profit Margin | 12.3% | 10.4% | 10.0% |
| EBITDA | 45.63M | 48.42M | 37.59M |
| Free Cash Flow | 26.06M | 26.05M | 25.67M |
| Rev Growth | -0.8% | +22.0% | +2.7% |
| Debt/Equity | 0.64 | 0.69 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |